Delayed administration of FG-3019 in the therapeutic regimen showed a trend toward decreased peritoneal hydroxyproline content, which was not statistically significant (Fig. 1a ).
← all excerpts
Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis.
1
—
—